Navigation Links
Nutrastar Releases Second Quarter 2013 Results

HARBIN, China, Aug. 12, 2013 /PRNewswire-FirstCall/ -- Nutrastar International Inc. (OTCQB: NUIN; "Nutrastar" or the "Company"), a leading producer and supplier of premium branded consumer products, including commercially cultivated Cordyceps Militaris ("Cordyceps"), health beverages and organic and specialty foods, today announced its financial results for the quarter and six months ended June 30, 2013.

Three Months Ended June 30, 2013 Financial Highlights

  • Net revenue increased 18.3% to $11.87 million, compared to $10.04 million in the three months ended June 30, 2012.
  • Gross profit increased 20.9% to $9.14 million, up from $7.56 million in the comparable 2012 quarter.
  • Gross margin was 77% compared with 75.4% in the second quarter 2012.
  • Net income was $5.96 million, up 21.7% from $4.90 million recorded in Q2 2012.
  • Basic and diluted EPS were $0.37 and $0.35, respectively, with 15.86 million basic and 16.99 million diluted shares outstanding.
  • Six Months Ended June 30, 2013 Financial Highlights

  • Net revenue increased 14.1% to $19.29 million, compared to $16.90 million in the six months ended June 30, 2012.
  • Gross profit increased 16.9% to $14.78 million, up from $12.65 million in the comparable 2012 six month period.
  • Gross margin was 76.6%, compared to 74.8% in the first six months of 2012.
  • Net income was $9.38 million, up 19.4% from $7.85 million in the first half of 2012.
  • Basic and diluted EPS were $0.58 and $0.55, respectively, with 15.86 million basic and 16.99 million diluted shares outstanding.
  • Management Commentary

    "In line with expectations, our financial results showed continued top-line growth, coupled with the robust progression of our bottom line. Gross margin expanded in the second quarter by 1.6% as a result of economics of scale due to increased capacity as well as an attractive product mix. The majority of revenues, roughly 74% in Q2, stemmed from our higher margin commercially cultivated Cordyceps, which saw sales hit $8.8 million, up 17.1% year-over-year. Premium functional health beverages contributed $2.5 million in the quarter, up 26.7% as a result of prior company-led marketing initiatives specifically designed to grow this market," stated, Ms. Lianyun Han, CEO of Nutrastar.

    Ms. Han continued, "As for the remainder of the year, we are confident in the continuation of our growth and expect to meet our full year 2013 revenue guidance. Demand for our premium consumer products remains steadfast and robust, especially among the affluent and elderly population. We remain committed to expanding our market, growing our brand awareness and bringing more products into the hands of health-conscious consumers. To this end, we plan to embark on new, fresh campaigns geared towards better informing and promoting the health benefits of our premium consumer products, especially our on-the-go functional health beverages and instant soluble drinks, which we believe will be key market drivers in the future. We look forward to updating our shareholders and the investment community on our progress on these initiatives in the coming months. Nutrastar is committed to full disclosure, we encourage any interested investor to visit our Cordyceps production facilities and experience the company's products firsthand."

    Financial Guidance

    Based on management's current expectations, the Company maintains its expectation that 2013 revenue will be in the range of $44 million to $46 million, representing an approximate 19% to 25% top line increase over last year.

    Nutrastar is providing the above guidance as a convenience to investors and assumes no obligation to update it.

    Request for Call with Management

    Investors are invited to schedule a call with Nutrastar's management team. For those investors who are interested in speaking with management, please contact American Capital Ventures at +1-305-918-7000 to schedule.

    For more information regarding Nutrastar's financial performance during the quarter ended June 30, 2013, please refer to the Quarterly Report Form 10-Q to be filed with the Securities and Exchange Commission on or about August 12, 2013.

    About Nutrastar International Inc.Nutrastar is a China based leading producer and supplier of premium branded consumer products including commercially cultivated Cordyceps Militaris, functional health beverages as well as specialty and organic foods. Cordyceps Militaris is one of the most highly regarded herbal nutrients in Traditional Chinese Medicine. The Company, with 330 employees, including 21 in R&D and 149 in sales and marketing, is located in Harbin, with its main operations in Heilongjiang Province. The products of Nutrastar are sold throughout China via a sales and distribution network that covers more than 10 provinces. More information may be found at or e-mail:

    Make sure you are first to receive timely up-to-date information on Nutrastar. Sign up for Nutrastar's email news alert system today at:

    Safe Harbor StatementThis news release contains "forward-looking statements" relating to the business of Nutrastar International Inc., its subsidiaries and other affiliate companies.  All statements, other than statements of historical fact included herein are "forward-looking statements" including statements concerning plans, objectives, goals, strategies, future events or performance, financial guidance, and underlying assumptions and other statements that are other than statements of historical facts.  These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the Company with the Securities and Exchange Commission. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Other than as required under the securities laws, the Company does not assume a duty to update any forward-looking statements to reflect events or circumstances after the date hereof.

    For more information, please contact: 

    Howard Gostfrand
    American Capital Ventures
    Tel: +1-305-918-7000

    For the Three MonthsFor the Six MonthsEnded June 30,Ended June 30,2013201220132012NET REVENUE





    16,896,446Cost of goods sold (2,731,416)(2,472,094)(4,503,704)(4,250,662)GROSS PROFIT 9,142,9187,563,33414,781,76612,645,784Selling expenses (473,793)(465,650)(904,256)(848,008)General and administrative expenses (696,752)(664,538)(1,289,267)(1,329,243)Income from operations 7,972,3736,433,14612,588,24310,468,533Other income (expenses): Interest income 78,74866,664162,489133,882Foreign exchange differences 31,644(13,571)26,457(11,167)Change in fair value of warrants 173144,788173140,759Total other income 110,565197,881189,119263,474Income before income taxes 8,082,9386,631,02712,777,36210,732,007Provision for income taxes (2,120,129)(1,729,994)(3,399,869)(2,881,396)NET INCOME 5,962,8094,901,0339,377,4937,850,611Earnings per share: Basic










    0.48Weighted average number of shares outstanding: Basic 15,863,82615,384,18015,863,82615,370,851Diluted 16,993,92616,517,69916,993,92616,513,952 NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETS
    (AMOUNTS EXPRESSED IN US DOLLARS) June 30,December 31,20132012(Unaudited)ASSETSCURRENT ASSETS  Cash and cash equivalents



    75,526,533 Accounts receivable 91,53181,497 Inventories 1,250,539965,251 Prepayments and other receivables 449,9211,321,726Total current assets 89,639,91877,895,007OTHER ASSETS  Intangible assets, net 1,335,9561,552,022 Property, plant and equipment, net 15,771,79015,991,060Total assets$106,747,664$95,438,089LIABILITIES AND STOCKHOLDERS' EQUITYCURRENT LIABILITIES  Other payables and accruals



    1,481,198 Taxes payable 2,833,0022,981,136 Due to a related party 159,360150,036 Preferred stock dividend payable 640,774528,528 Warrants liabilities -173Total current liabilities 5,447,4945,141,071Total liabilities 5,447,4945,141,071COMMITMENTS AND CONTINGENCIES (Note 17) STOCKHOLDERS' EQUITY   Preferred Stock, $0.001 par value, 1,000,000 shares authorized, 113,010
      shares issued and outstanding; aggregate liquidation preference amount:
      $3,164,280 and $3,164,280, plus accrued but unpaid dividend of $640,774
      and $528,528, at June 30, 2013 and December 31, 2012, respectively 2,577,3242,577,324  Common stock, $0.001 par value, 190,000,000 shares authorized,
    5,907,381 shares issued and 15,863,826 shares outstanding at
    June 30, 2013 and December 31, 201215,90815,908 Additional paid-in capital 19,138,19919,029,586 Statutory reserves 4,964,5624,960,023 Treasury stock, at cost, 43,555 shares
    as of June 30, 2013 and December 31, 2012(78,767)(78,767) Retained earnings 67,586,64058,325,932 Accumulated other comprehensive income 7,096,3045,467,012Total stockholders' equity 101,300,17090,297,018Total liabilities and stockholders' equity$106,747,664$95,438,089 NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES
    For the Six Months EndedJune 30,20132012CASH FLOWS FROM OPERATING ACTIVITIES: Net income



    7,850,611Adjustments to reconcile net income to cash provided by operating activities: Change in fair value of warrants (173)(140,759)Depreciation and amortization 731,128618,482Share-based compensation expense 108,613207,964(Increase) decrease in assets: Accounts receivable (8,537)(6,744)Inventories (265,896)(492,222)Prepayments and other receivables 885,634912,912Increase (decrease) in liabilities: Accounts payable -(6,332)Other payables and accruals 305,355155,434Taxes payable (197,651)(217,584)Net cash provided by operating activities 10,935,9668,881,762CASH FLOWS FROM INVESTING ACTIVITIES: Advances from sale of fixed assets -1,268,351Purchase of property, plant and equipment -(15,926)Net cash provided by investing activities -1,252,425CASH FLOWS FROM FINANCING ACTIVITIES: Decrease in restricted cash -4,170Purchase of common stock -(69,214)(Repayment to) advance from related party (27,009)77,143Net cash (used in) provided by financing activities (27,009)12,099Foreign currency translation adjustment 1,412,437(232,209)INCREASE IN CASH AND CASH EQUIVALENTS12,321,3949,914,077CASH AND CASH EQUIVALENTS, at the beginning of the period 75,526,53354,556,329CASH AND CASH EQUIVALENTS, at the end of the period$87,847,927$64,470,406NON-CASH TRANSACTIONS Preferred stock and dividend converted into common stock



    995,587Preferred stock dividend payable 112,246138,874Share-based payment to officers and directors under equity incentive plan 108,613207,964SUPPLEMENTAL DISCLOSURE INFORMATION Income taxes paid




    SOURCE Nutrastar International Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Nutrastar Announces First Quarter 2013 Results, Maintains Full Year Revenue Guidance Range of $44 million to $46 Million
    2. Nutrastar Announces Full Year 2012 Results, Issues 2013 Revenue Guidance
    3. Nutrastar International Completes Multi-Year Production Expansion Project Bringing Cordyceps Capacity to 100 Tons
    4. Techne Corporation Releases Unaudited Fourth Quarter And Fiscal Year 2013 Results
    5. Bekers Hospital Review Releases Report on State of Hospital Industry
    6. Beckers Healthcare Releases Report on State of ASC Industry
    7. Earnings Releases, Investment Plans, Commencement of Clinical Trials, and FDA Applications Brighten Outlook - Research Report on Bard, Centene, Exact Sciences, Ironwood, and Merrimack
    8. Endeavor Power Corporation Issues Corrections on two of its earlier Press Releases dated January 9, 2013 and March 8, 2013
    9. Releases its e-Book for Year 2013
    10. RxAlly Releases White Paper on Necessity of Personalized Pharmacist Care
    11. TRACE Releases 2012 Global Enforcement Report
    Post Your Comments:
    (Date:11/26/2015)... , Nov. 26, 2015 Research and ... the "Advanced Wound Care Market by Type (Dressings, ... End User (In-Patient Facility, Out-Patient Facility), and Geography - ... --> --> ... description, definition and forecast of the global advanced wound ...
    (Date:11/26/2015)... ) has announced ... High Viscosity Drugs" report to their offering. ... addition of the "Self Administration of High ... --> Research and Markets ( ) ... Administration of High Viscosity Drugs" report to ...
    (Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the European Cell Surface Marker Testing ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
    Breaking Medicine Technology:
    (Date:11/27/2015)... VVA (PRWEB) , ... November 27, 2015 , ... ... motto of progress through sharing, the 2016 Building Better Radiology Marketing ... The conference will begin on Sunday, March 6, 2016, at Caesars Palace in ...
    (Date:11/27/2015)... ... November 27, 2015 , ... CBD College is proud to ... Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. CBD College is honored ... one of twelve colleges and universities in the state of California make the cut. ...
    (Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity Point ... come together on Thanksgiving Day to share the things that they are most ... Serenity Point YouTube channel, patients displayed what they wrote on index cards, describing ...
    (Date:11/26/2015)... ... , ... Jobs in hospital medical laboratories and in the imaging field lead ... Aureus Medical Group . These fields, as well as travel nursing, ... healthcare jobs through the company’s website, , The leading healthcare staffing ...
    (Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of the ... to improve system efficiency and reliability. , The new Q-Suite 6 platform is based ... system avoids locking itself into a specific piece of software for many key components ...
    Breaking Medicine News(10 mins):